Frontlight ResearchEarly access
HIV trials in Mozambique
5 of 8 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleThe Women's Screening and Self-Testing Program (PROMETA) Study
- Where
- Maputo
- Age
- 25 years to 49 years
- People
- 8,445
- Run by
- Tulane University
See details and how to joinNCT06810739 - Phase 2Not yet taking people in MozambiqueTnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis
- Where
- Maputo
- Age
- 18 years and over
- People
- 130 worldwide
- Run by
- ANRS, Emerging Infectious Diseases
See details and how to joinNCT05590455 - Phase 3Not yet taking people in MozambiqueNdovu RCT: Investing the Optimal Management of Dolutegravir Resistance
- Where
- Beira, Maputo
- Age
- 3 years and over
- People
- 392 worldwide
- Run by
- University of Nairobi
See details and how to joinNCT06747507 - Phase 3Not yet taking people in MozambiqueReducing Mortality in Adults With Advanced HIV Disease (REVIVE)
- Where
- Maputo
- Age
- 18 years and over
- People
- 8,000 worldwide
- Run by
- Population Health Research Institute
See details and how to joinNCT05580666 - No phaseTaking peopleAssessment of the Effectiveness of TA Versus LEEP for Cervical Cancer Risk Reduction in WLHIV in Mozambique
- Where
- Maputo
- Age
- 25 years to 49 years
- People
- 4,844
- Run by
- Instituto Nacional de Saúde, Mozambique
See details and how to joinNCT06326294